These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9395317)

  • 1. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
    Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
    Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
    Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
    Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
    Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
    J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides.
    Subbarao NK; Fielding CJ; Hamilton RL; Szoka FC
    Proteins; 1988; 3(3):187-98. PubMed ID: 3255105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
    Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of lipid-binding and lecithin:cholesterol acyltransferase activation of the amino- and carboxyl-terminal domains of human apolipoprotein E3.
    De Pauw M; Vanloo B; Weisgraber K; Rosseneu M
    Biochemistry; 1995 Aug; 34(34):10953-66. PubMed ID: 7662677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the hydrophobicity gradient to the secondary structure and activity of fusogenic peptides.
    Decout A; Labeur C; Vanloo B; Goethals M; Vandekerckhove J; Brasseur R; Rosseneu M
    Mol Membr Biol; 1999; 16(3):237-46. PubMed ID: 10503245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation.
    Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW; Landrum M
    J Biol Chem; 1998 May; 273(19):11776-82. PubMed ID: 9565601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-II.
    Benetollo C; Lambert G; Talussot C; Vanloo E; Cauteren TV; Rouy D; Dubois H; Baert J; Kalopissis A; Denèfle P; Chambaz J; Brasseur R; Rosseneu M
    Eur J Biochem; 1996 Dec; 242(3):657-64. PubMed ID: 9022694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
    Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
    J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.
    Roosbeek S; Vanloo B; Duverger N; Caster H; Breyne J; De Beun I; Patel H; Vandekerckhove J; Shoulders C; Rosseneu M; Peelman F
    J Lipid Res; 2001 Jan; 42(1):31-40. PubMed ID: 11160363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
    Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP
    Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.
    Pownall HJ; Hu A; Gotto AM; Albers JJ; Sparrow JT
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3154-8. PubMed ID: 6774331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions.
    Rogers DP; Roberts LM; Lebowitz J; Datta G; Anantharamaiah GM; Engler JA; Brouillette CG
    Biochemistry; 1998 Aug; 37(34):11714-25. PubMed ID: 9718294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
    Johnson JE; Rao NM; Hui SW; Cornell RB
    Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity.
    Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW
    J Biol Chem; 1997 Mar; 272(11):7278-84. PubMed ID: 9054424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation.
    Emmanuel F; Steinmetz A; Rosseneu M; Brasseur R; Gosselet N; Attenot F; Cuiné S; Séguret S; Latta M; Fruchart JC
    J Biol Chem; 1994 Nov; 269(47):29883-90. PubMed ID: 7961983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies of a peptide activator of human lecithin-cholesterol acyltransferase.
    Buchko GW; Treleaven WD; Dunne SJ; Tracey AS; Cushley RJ
    J Biol Chem; 1996 Feb; 271(6):3039-45. PubMed ID: 8621698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity.
    Peelman F; Verschelde JL; Vanloo B; Ampe C; Labeur C; Tavernier J; Vandekerckhove J; Rosseneu M
    J Lipid Res; 1999 Jan; 40(1):59-69. PubMed ID: 9869650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.